The success of GLP-1 medications for treating Type 2 diabetes and obesity naturally leads to a related question: Do GLP-1 drugs affect cancer risk, which is often associated with obesity and Type...

The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal cancer, following encouraging results from a clinical trial led in part...

For more than 35 years, University of Oklahoma Health Campus researchers have played a key role in the Strong Heart Study, a landmark project that has uncovered critical insights into...

Abdul Rafeh Naqash, M.D., associate professor at the University of Oklahoma College of Medicine and an oncologist at OU Health Stephenson Cancer Center, has been named a fellow of the American...

OKLAHOMA CITY – More than 800 people attended the 2025 Connect+Cure Gala on Wednesday night, raising $4.7 million to support research and programs at the University of Oklahoma Health Harold...